Effect of Co-culturing both placenta-derived mesenchymal stem cells and their condition medium in the cancer cell (HepG2) migration, damage through apoptosis and cell cycle arrest
Human placental-derived mesenchymal stem cells (hPMSCs) are a promising candidate to inhibit the proliferation of hepatocellular carcinoma (HCC) cell lines such as HepG2. The effects of hPMSCs and their conditioned media on HepG2 are, however, still a mystery. As a result, the goal of this study was...
Main Authors: | F.A. Dain Md Opo, Mohammed Moulay, Ghadeer I. Alrefaei, Nouf H. Alsubhi, Saleh Alkarim, Mohammed M. Rahman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Saudi Journal of Biological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319562X22004351 |
Similar Items
-
TGFβ-Treated Placenta-Derived Mesenchymal Stem Cells Selectively Promote Anti-Adipogenesis in Thyroid-Associated Ophthalmopathy
by: Hyun-Ah Shin, et al.
Published: (2022-05-01) -
Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves’ ophthalmopathy
by: Mira Park, et al.
Published: (2019-08-01) -
Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells
by: Yunqi Yao, et al.
Published: (2021-05-01) -
Side population cells derived from hUCMSCs and hPMSCs could inhibit the malignant behaviors of Tn+ colorectal cancer cells from modifying their O-glycosylation status
by: Wen Hu, et al.
Published: (2023-05-01) -
Characterization of mitochondrial iron uptake in HepG2 cells
by: DORA INÉS MAZARIEGOS, et al.
Published: (2006-01-01)